Literature DB >> 11240657

Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society.

E. I. Kohorn1, D. P. Goldstein, B. W. Hancock, S. J. Kim, J. R. Lurain, E. Newlands, J. T. Soper, L. C. Wong.   

Abstract

During the past 5 years the International Society for the Study of Trophoblastic Disease and the International Gynecological Cancer Society have moved to modify the staging system for trophoblastic disease by combining the staging of the International Federation of Gynecology and Obstetrics (FIGO) with the scoring system of the World Health Organization (WHO). By making significant changes in both, the classification will be more acceptable worldwide leading to uniform use by physicians reporting management results in trophoblastic disease. This is the report of the Rome Workshop, which will be presented for ratification to the FIGO Staging Committee in September 2000.

Entities:  

Year:  2000        PMID: 11240657     DOI: 10.1046/j.1525-1438.2000.00002.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).

Authors:  S McGrath; D Short; R Harvey; P Schmid; P M Savage; M J Seckl
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

2.  False-positive beta-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease.

Authors:  V M Díaz Muñoz de la Espada; J A Arranz Arija; P Khosravi Shahi; S Encinas García; R Alvarez Alvarez; R González Beca
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

Review 3.  Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Authors:  Mo'iad Alazzam; John Tidy; Raymond Osborne; Robert Coleman; Barry W Hancock; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2016-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.